Back

New oral anticoagulants (NOACs) in patients undergoing cardiac procedures: latest evidence.

18 March 2018 (13:10 - 13:25)
Organised by:
Congress Presentation Part of: Leading the way in anticoagulation care in Atrial Fibrillation (AF) patients Acute Management of Atrial Fibrillation EHRA Premium Access EHRA 2018

About the speaker

Photo
Professor Stefan H Hohnloser

Johann Wolfgang Goethe University, Frankfurt (Germany)

4 More presentations in this session

Presentation thumbnail
Burden of atrial fibrillation: the case for change.
Professor J. Camm (London, GB)
Presentation thumbnail
Translating New Oral Anticoagulant (NOAC) evidence into clinical practice: optimising patient outcomes.
Professor G. Lip (Liverpool, GB)
Presentation thumbnail
Patient education: practical approach.
Professor H. Heidbuchel (Edegem, BE)
Presentation thumbnail
Questions & Answers - Leading the way in anticoagulation care in AF patients.
Professor J. Camm (London, GB) Professor H. Heidbuchel (Edegem, BE) Professor G. Lip (Liverpool, GB) Professor S. Hohnloser (Frankfurt, DE)

Access the full session

Session thumbnail
Leading the way in anticoagulation care in Atrial Fibrillation (AF) patients

The Event

Event poster

EHRA 2018

18 March 2018 13:10 CET
You may be interested in
thumbnail
Congress Presentation
Perioperative management of antithrombotic therapy.
29 August 2022
thumbnail
Congress Presentation
Direct oral anticoagulants vs warfarin in non-valvular atrial fibrillation. Meta-analysis, includes all published trials.
27 August 2021
thumbnail
Congress Session
LAAC and AF ablation are evolving, are you?
31 March 2025
thumbnail
Congress Presentation
Oral anticoagulation in 13,344 adult patients with congenital heart disease (ACHD) in a longitudinal real-world setting in 2005-2017
2 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources